For more information:
AAPS Communications Manager
The AAPS Journal Impact Factor Grows from 3.6 to 4.5
Arlington, VA—AAPS is pleased to announce that the impact factor for The AAPS Journal grew from 3.6 to 4.5 in 2022.
This is an exciting accomplishment made more significant by timing. Several journals in the pharmaceutical space saw their impact factors drop as Clarivate’s citation calculation changed, and citations of COVID-19-relevant articles eased.
“The editorial team of The AAPS Journal is pleased to note the rise in the Journal’s impact factor this year,” Editor-in-Chief Ho-Leung Fung, Ph.D., said. “We strive to publish articles of significant impact in our field. We hope to continue to serve as a leading venue for publishing important research by pharmaceutical scientists worldwide.”
“The AAPS Journal has proven to be a forum for credible, cutting-edge research backed by a robust peer review process,” AAPS President Patrick Sinko, Ph.D., said. “I credit the success of the journal to the strong and dedicated leadership of Dr. Fung, who has led the publication for 18 years.”
Dr. Fung will step down as Editor-in-Chief of The AAPS Journal at the end of 2023. AAPS is in the process of evaluating candidates for the position.
AAPS members have free, unlimited, electronic access to articles in AAPS’ four peer-reviewed journals. To access The AAPS Journal, visit the journal website.
American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online.